Genzyme acquiring SangStat

GENZ will buy SANG for about $600 million in cash, or $22.50 per share. The take out price is a 45% premium to SANG's Friday close at $15.48. GENZ

Read the full 299 word article

How to gain access

Continue reading with a
two-week free trial.